Shibayama, Katsuhiro et al. published their patent in 1992 |CAS: 38939-88-7

The Article related to tricyclic triazole preparation antiinflammatory, antiallergic triazoloquinoxaline triazolobenzodiazepine, platelet activating factor antagonist triazoloquinoxaline, paf antagonist triazoloquinoxaline, blood platelet aggregation inhibitor triazoloquinoxaline, triazolobenzimidazole antiinflammatory and other aspects.Formula: C7H6ClNO2

On October 29, 1992, Shibayama, Katsuhiro; Makino, Tetsuya; Imaoka, Takayuki; Katou, Tetsuya; Kaneko, Masayuki published a patent.Formula: C7H6ClNO2 The title of the patent was Preparation of tricyclic triazole derivatives as antiinflammatory, antiallergic, and anti-platelet activating factor (PAF) drugs. And the patent contained the following:

The title compounds [I; R1 = H, alkyl, C3-5 cycloalkyl; R2, R3 = H, alkyl, alkoxy, halo; W = CO, CR4R5; R4, R5 = H, alkyl; A = C1-5 linear or branched (un)saturated alkylene optionally containing heteroatoms; l = 0-2; n = 1-3; Y = N, C; Z = C(B)Ar1Ar2, CAr1Ar2, OCHAr1Ar2, fused aromatic ring; B = H, HO, MeO; Ar1, Ar2 = H, (un)substituted aryl] are prepared Thus, cyclocondensation of 4-(3-ethoxypropyl)-2-chloroquinoxaline (preparation given) with acetohydrazide in BuOH under reflux and bromination of the the resulting [1,2,4]triazolo[4,3-a]quinoxaline derivative (II; R6 = OEt) with 48% HBr followed by condensation with 4-(diphenylmethylene)piperidine and NaCO3 in DMF at 60-70° gave a title compound (II; R6 = Q). I at 50 mg/kg p.o. inhibited 44-75% passive cutaneous anaphylaxis and 19-87% histamine-induced allergy in rats. I showed IC50 of 0.013-5.4 μg/mL for inhibiting PAF-induced rabbit’s blood platelet aggregation. A tablet formulation containing II (R6 = Q1) was given. A total of 121 I were prepared The experimental process involved the reaction of 2-Chloro-4-methyl-1-nitrobenzene(cas: 38939-88-7).Formula: C7H6ClNO2

The Article related to tricyclic triazole preparation antiinflammatory, antiallergic triazoloquinoxaline triazolobenzodiazepine, platelet activating factor antagonist triazoloquinoxaline, paf antagonist triazoloquinoxaline, blood platelet aggregation inhibitor triazoloquinoxaline, triazolobenzimidazole antiinflammatory and other aspects.Formula: C7H6ClNO2

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

He, Zhi-Tao et al. published their research in Nature Communications in 2019 |CAS: 98946-18-0

The Article related to aryl cyclobutyl ester preparation, cyclobutyl ester aryl bromide alpha arylation palladium catalyst, azetidinyl ester aryl preparation, azetidine ester aryl bromide alpha arylation palladium catalyst, cyclopropyl ester aryl preparation, bromoarene cyclopropyl ester alpha arylation palladium catalyst and other aspects.Related Products of 98946-18-0

On December 31, 2019, He, Zhi-Tao; Hartwig, John F. published an article.Related Products of 98946-18-0 The title of the article was Palladium-catalyzed α-arylation for the addition of small rings to aromatic compounds. And the article contained the following:

A generally applicable approach to attach small rings to a wide range of aromatic compounds by palladium-catalyzed α-arylation of cyclopropyl, cyclobutyl and azetidinyl esters was reported. The direct α-arylation of cyclopropyl esters and cyclobutyl esters was achieved in high yield by ensuring that rate of coupling exceeded rate of Claisen condensation. The α-arylation of azetidines was achieved without ring opening of strained saturated heterocycle by conducting reactions with an azetidine derivative bearing a benzyl protecting group on nitrogen. Mechanistic studies showed that α-arylation of small rings was challenging because of the weak acidity of α C-H bond (cyclopropanes), strong sensitivity of strained esters to Claisen condensation (cyclobutatanes), or facile decomposition of enolates (azetidinyl esters). The experimental process involved the reaction of tert-Butyl trichloroacetimidate(cas: 98946-18-0).Related Products of 98946-18-0

The Article related to aryl cyclobutyl ester preparation, cyclobutyl ester aryl bromide alpha arylation palladium catalyst, azetidinyl ester aryl preparation, azetidine ester aryl bromide alpha arylation palladium catalyst, cyclopropyl ester aryl preparation, bromoarene cyclopropyl ester alpha arylation palladium catalyst and other aspects.Related Products of 98946-18-0

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Albrecht, Dominik et al. published their research in Chemistry – A European Journal in 2010 |CAS: 14602-86-9

The Article related to alkenyl substituted valerolactam selenylation elimination, dihydropyridinone alkenyl substituted derivative preparation photocycloaddition, piperidinone tricyclic derivative stereoselective preparation chiral complexing reagent, kemp triacid tetrahydroaminonaphthol chiral template preparation resolution and other aspects.Electric Literature of 14602-86-9

Albrecht, Dominik; Vogt, Florian; Bach, Thorsten published an article in 2010, the title of the article was Diastereo- and Enantioselective Intramolecular [2+2] Photocycloaddition Reactions of 3-(ω’-Alkenyl)- and 3-(ω’-Alkenyloxy)-Substituted 5,6-Dihydro-1H-pyridin-2-ones.Electric Literature of 14602-86-9 And the article contains the following content:

3-(ω’-Alkenyl)-substituted 5,6-dihydro-1H-pyridin-2-ones I (n = 1-3) were prepared as photocycloaddition precursors either by cross-coupling from 3-iodo-5,6-dihydro-1H-pyridin-2-one or, more favorably, from the corresponding α-(ω’-alkenyl)-substituted δ-valerolactams by a selenylation/elimination sequence (56-62% overall yield). 3-(ω’-Alkenyloxy)-substituted 5,6-dihydro-1H-pyridin-2-ones II (n = 1, 2) were accessible in 43 and 37% overall yield from 3-diazopiperidin-2-one by an α,α-chloroselenylation reaction at the 3-position followed by nucleophilic displacement of a chloride ion with an ω-alkenolate and oxidative elimination of selenoxide. Upon irradiation at λ = 254 nm, the precursor compounds underwent a clean intramol. [2+2] photocycloaddition reaction. The substrates tethered by a two-atom chain exclusively delivered the resp. crossed products III (X = CH2, O), and the substrates tethered by longer chains, gave the straight products IV (n = 1, X = CH2, O; n = 2, X = CH2). The completely regio- and diastereoselective photocycloaddition reactions proceeded in 63-83% yield. Irradiation in the presence of the chiral templates (-)-V and (+)-VI at -75° in toluene rendered the reactions enantioselective with selectivities varying between 40 and 85% ee. Truncated template rac-VI was prepared as a noranalogue of the well-established template V in eight steps and 56% yield from the Kemp triacid. Subsequent resolution delivered the enantiomerically pure templates (-)-ent-VI and (+)-VI. The outcome of the reactions is compared to the results achieved with 4-substituted 5,6-dihydro-1H-pyridin-2-ones and quinolones. The experimental process involved the reaction of (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl carbonochloridate(cas: 14602-86-9).Electric Literature of 14602-86-9

The Article related to alkenyl substituted valerolactam selenylation elimination, dihydropyridinone alkenyl substituted derivative preparation photocycloaddition, piperidinone tricyclic derivative stereoselective preparation chiral complexing reagent, kemp triacid tetrahydroaminonaphthol chiral template preparation resolution and other aspects.Electric Literature of 14602-86-9

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Sakhautdinov, I. M. et al. published their research in Russian Journal of General Chemistry in 2018 |CAS: 35444-44-1

The Article related to chlorooxoheptanoate bromooxoheptanoate preparation bingel cyclopropanation reaction c60, octadienoate preparation phosphine catalyzed cycloaddition c60, cyclopropafullerene cyclopentenofullerene preparation, bingel cyclopropanation chlorooxoheptanoate bromooxoheptanoate c60, cycloaddition octadienoate c60 and other aspects.Product Details of 35444-44-1

On December 31, 2018, Sakhautdinov, I. M.; Mukhamet’yanova, A. F. published an article.Product Details of 35444-44-1 The title of the article was Cycloaddition of Bromo(chloro)methyl Ketones and Allenoates of Adipic Acid Monoesters to Fullerene C60. And the article contained the following:

Chloro- and bromoketones XCH2CO(CH2)4CO2R (R = Me, Et; X = Cl, Br) and allenoates MeO2CCH:C:CH(CH2)3CO2R (R = Me, Et) were prepared from monomethyl and monoethyl adipates and subjected to Bingel cyclopropanation and phosphine-catalyzed cycloaddition reactions, resp., with fullerene-C60 to yield cyclopropa- and cyclopentenofullerenes. The use of chloroketones in the Bingel reaction gave higher product yields than the use of bromoketones; the cycloaddition of allenoates to C60 gave products in higher yields than the Bingel cycloadditions The experimental process involved the reaction of Methyl 6-chloro-6-oxohexanoate(cas: 35444-44-1).Product Details of 35444-44-1

The Article related to chlorooxoheptanoate bromooxoheptanoate preparation bingel cyclopropanation reaction c60, octadienoate preparation phosphine catalyzed cycloaddition c60, cyclopropafullerene cyclopentenofullerene preparation, bingel cyclopropanation chlorooxoheptanoate bromooxoheptanoate c60, cycloaddition octadienoate c60 and other aspects.Product Details of 35444-44-1

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Xu, Youwen et al. published their research in Chemistry – A European Journal in 2018 |CAS: 98946-18-0

The Article related to asparagine 11c labeled enantioselective total radiosynthesis pet imaging agent, chiral cyclic sulfamidate precursor ring opening nucleophilic cyanation hydrolysis, amino acid crystal structure, racemization cyanation kinetics reaction mechanism, amino acids, nucleophilic, radiochemistry, ring opening, sulfamidate and other aspects.Safety of tert-Butyl trichloroacetimidate

Xu, Youwen; Cankaya, Aylin Sibel; Hoque, Ruma; Lee, So Jeong; Shea, Colleen; Kersting, Lena; Schueller, Michael; Fowler, Joanna S.; Szalda, David; Alexoff, David; Riehl, Barbara; Gleede, Tassilo; Ferrieri, Richard A.; Qu, Wenchao published an article in 2018, the title of the article was Synthesis of L-[4-11C]asparagine by ring-opening nucleophilic 11C-cyanation reaction of a chiral cyclic sulfamidate precursor.Safety of tert-Butyl trichloroacetimidate And the article contains the following content:

The development of a convenient and rapid method to synthesize radiolabeled, enantiomerically pure amino acids (AAs) as potential positron emission tomog. (PET) imaging agents for mapping various biochem. transformations in living organisms remains a challenge. This is especially true for the synthesis of carbon-11-labeled AAs given the short half-life of carbon-11 (11C, t1/2=20.4 min). A facile synthetic pathway to prepare enantiomerically pure 11C-labeled L-asparagine was developed using a partially protected serine as a starting material with a four-step transformation providing a chiral five-membered cyclic sulfamidate as the radiolabeling precursor. Its structure and absolute configuration were confirmed by X-ray crystallog. Utilizing a [11C]cyanide nucleophilic ring opening reaction followed by selective acidic hydrolysis and deprotection, enantiomerically pure L-[4-11C]asparagine was synthesized. Further optimization of reaction parameters, including base, metal ion source, solvent, acid component, reaction temperature and reaction time, a reliable two-step method for synthesizing L-[4-11C]asparagine was presented: within a 45±3 min (n = 5, from end-of-bombardment), the desired enantiomerically pure product was synthesized with the initial nucleophilic cyanation yield of 69±4 % (n = 5) and overall two-step radiochem. yield of 53±2 % (n = 5) based on starting [11C]HCN, and with radiochem. purity of 96±2 % (n = 5). The experimental process involved the reaction of tert-Butyl trichloroacetimidate(cas: 98946-18-0).Safety of tert-Butyl trichloroacetimidate

The Article related to asparagine 11c labeled enantioselective total radiosynthesis pet imaging agent, chiral cyclic sulfamidate precursor ring opening nucleophilic cyanation hydrolysis, amino acid crystal structure, racemization cyanation kinetics reaction mechanism, amino acids, nucleophilic, radiochemistry, ring opening, sulfamidate and other aspects.Safety of tert-Butyl trichloroacetimidate

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Schwenk, R. et al. published their research in Dalton Transactions in 2015 |CAS: 14602-86-9

The Article related to xyliphos fluoromethyl iridium catalyst preparation hydrogenation enantioselective dihydroisoquinoline hydrochloride, fluoromethyl phosphinylferrocenyl iridium preparation hydrogenation catalyst enantioselective hydroisoquinoline hydrochloride, crystal mol structure fluoromethyl xyliphos platinum iridium preparation and other aspects.Reference of (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl carbonochloridate

Schwenk, R.; Togni, A. published an article in 2015, the title of the article was P-Trifluoromethyl ligands derived from Josiphos in the Ir-catalysed hydrogenation of 3,4-dihydroisoquinoline hydrochlorides.Reference of (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl carbonochloridate And the article contains the following content:

The synthesis of mono P-trifluoromethyl and therefore P-stereogenic Xyliphos-derived ligands CpFeC5H3(PPhCF3)(CMeHP(xyl)2) (5, xyl = C6H3Me2-3,5) and their application in the Ir-catalyzed enantioselective hydrogenation of 1-substituted 3,4-dihydroisoquinolinium species (DHIQ) are reported. The ligands were prepared following previous procedures involving the reaction of a bis(trifluoromethyl)phosphine with lithiated (R)-Ugi amine (R)-CpFeC5H3Li(CHMeNMe2) (1). Chloroiridium(I) cyclooctadiene precatalysts containing these new partially electron-poor ligands are poorly active in the hydrogenation of free 1-phenyl-3,4-dihydroisoquinoline (12a). However, the corresponding hydrochloride 12a·HCl was smoothly reduced at 55-60° and 100 bar H pressure. The (SP)-configured ligand (SP)-5 yielded significantly higher enantioselectivity in hydrogenation experiments than its P-stereoisomeric counterpart (RP)-5. These new ligands were subsequently applied in the hydrogenation of twelve different 1-substituted 3,4-DHIQ chlorides. Good to excellent enantioselectivity was observed for substrates bearing relatively large substituents in position 1, reaching 96% ee for 1-Ph-DHIQ chloride 12a·HCl without the help of any additives. Furthermore, an interesting counterion effect was found with chloride being the best and hexafluorophosphate being very detrimental to enantioselectivity. The experimental process involved the reaction of (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl carbonochloridate(cas: 14602-86-9).Reference of (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl carbonochloridate

The Article related to xyliphos fluoromethyl iridium catalyst preparation hydrogenation enantioselective dihydroisoquinoline hydrochloride, fluoromethyl phosphinylferrocenyl iridium preparation hydrogenation catalyst enantioselective hydroisoquinoline hydrochloride, crystal mol structure fluoromethyl xyliphos platinum iridium preparation and other aspects.Reference of (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl carbonochloridate

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Pollack, Scott R. et al. published their research in Journal of Organic Chemistry in 2021 |CAS: 14602-86-9

The Article related to carbamate alkoxyacrylate acid catalyst metal free diastereoselective condensation reaction, dialkoxypropanoate carbamate acid catalyst metal free diastereoselective condensation reaction, propynoate carbamate base catalyst diastereoselective condensation reaction, aminoacrylate preparation stereoselective metal free and other aspects.HPLC of Formula: 14602-86-9

On September 3, 2021, Pollack, Scott R.; Dion, Amelie published an article.HPLC of Formula: 14602-86-9 The title of the article was Metal-free stereoselective synthesis of (E)- and (Z)-N-monosubstituted β-aminoacrylates via condensation reactions of carbamates. And the article contained the following:

Two efficient, stereoselective methods for the preparation of (E)- or (Z)-β-aminoacrylates via acid- or base-promoted condensation reactions of carbamates are described. The base-promoted reaction is E-selective, while acid catalysis can, through the choice of solvent, selectively form E or Z. The acid-catalyzed E-selective process proceeds through a crystallization obviating the need for chromatog. purification The experimental process involved the reaction of (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl carbonochloridate(cas: 14602-86-9).HPLC of Formula: 14602-86-9

The Article related to carbamate alkoxyacrylate acid catalyst metal free diastereoselective condensation reaction, dialkoxypropanoate carbamate acid catalyst metal free diastereoselective condensation reaction, propynoate carbamate base catalyst diastereoselective condensation reaction, aminoacrylate preparation stereoselective metal free and other aspects.HPLC of Formula: 14602-86-9

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Sun, Chang-Liang et al. published their research in Angewandte Chemie, International Edition in 2013 |CAS: 35444-44-1

The Article related to alkadienoic acid stereoselective preparation, pateamine a fragment stereoselective preparation, granulatamide b stereoselective preparation, alpha pyrone stereoselective ring opening iron catalyst methyl grignard, methylhexadienoic acid mol crystal structure, cross-coupling, dienes, heterocycles, iron, natural products and other aspects.COA of Formula: C7H11ClO3

Sun, Chang-Liang; Fuerstner, Alois published an article in 2013, the title of the article was Formal Ring-Opening/Cross-Coupling Reactions of 2-Pyrones: Iron-Catalyzed Entry into Stereodefined Dienyl Carboxylates.COA of Formula: C7H11ClO3 And the article contains the following content:

In the presence of Fe(acac)3, α-pyrones such as 4,6-dimethyl-2-pyrone underwent stereoselective and chemoselective ring opening reactions with MeMgBr in Et2O at -60° to give (2Z)-2,4-pentadienoic acids such as (Z)-Me2C:CHCMe:CHCO2H in 68-94% yields and in 7:1->20:1 diastereoselectivities; if the reactions were warmed to ambient temperature during reaction, (E)-alkadienoic acids were isolated stereoselectively. The method was used to prepare the dodecadienamide natural product granulatamide B and a fragment of the marine natural product pateamine A. The structure of (Z)-Me2C:CHCMe:CHCO2H was determined by X-ray crystallog. The experimental process involved the reaction of Methyl 6-chloro-6-oxohexanoate(cas: 35444-44-1).COA of Formula: C7H11ClO3

The Article related to alkadienoic acid stereoselective preparation, pateamine a fragment stereoselective preparation, granulatamide b stereoselective preparation, alpha pyrone stereoselective ring opening iron catalyst methyl grignard, methylhexadienoic acid mol crystal structure, cross-coupling, dienes, heterocycles, iron, natural products and other aspects.COA of Formula: C7H11ClO3

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

LaMarche, Matthew J. et al. published their research in Journal of Medicinal Chemistry in 2011 |CAS: 35444-44-1

The Article related to antibiotic natural product ge2270a aminothiazolyl analog synthesis structure activity, macrocyclic peptidomimetic antibacterial structure activity solubility stability pharmacokinetic, elongation factor tu inhibitor aminothiazolyl ge2270a analog cycloalkylcarboxylic acid, ge2270a acylation azidation curtius rearrangement and other aspects.HPLC of Formula: 35444-44-1

On December 8, 2011, LaMarche, Matthew J.; Leeds, Jennifer A.; Amaral, Kerri; Brewer, Jason T.; Bushell, Simon M.; Dewhurst, Janetta M.; Dzink-Fox, JoAnne; Gangl, Eric; Goldovitz, Julie; Jain, Akash; Mullin, Steve; Neckermann, Georg; Osborn, Colin; Palestrant, Deborah; Patane, Michael A.; Rann, Elin M.; Sachdeva, Meena; Shao, Jian; Tiamfook, Stacey; Whitehead, Lewis; Yu, Donghui published an article.HPLC of Formula: 35444-44-1 The title of the article was Antibacterial optimization of 4-aminothiazolyl analogues of the natural product GE2270 A: Identification of the cycloalkylcarboxylic acids. And the article contained the following:

4-Aminothiazolyl analogs of the antibiotic natural product GE2270 A were designed, synthesized, and optimized for their activity against Gram pos. bacterial infections. Optimization efforts focused on improving the physicochem. properties (e.g., aqueous solubility and chem. stability) of the 4-aminothiazolyl natural product template while improving the in vitro and in vivo antibacterial activity. Structure-activity relationships were defined, and the solubility and efficacy profiles were improved over those of previous analogs and GE2270 A. These studies identified novel, potent, soluble, and efficacious elongation factor-Tu inhibitors, which bear cycloalkylcarboxylic acid side chains, and culminated in the selection of development candidates amide (I) (R1 = C:O) and urethane I (R1 = OC:O). The experimental process involved the reaction of Methyl 6-chloro-6-oxohexanoate(cas: 35444-44-1).HPLC of Formula: 35444-44-1

The Article related to antibiotic natural product ge2270a aminothiazolyl analog synthesis structure activity, macrocyclic peptidomimetic antibacterial structure activity solubility stability pharmacokinetic, elongation factor tu inhibitor aminothiazolyl ge2270a analog cycloalkylcarboxylic acid, ge2270a acylation azidation curtius rearrangement and other aspects.HPLC of Formula: 35444-44-1

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Kajino, Masahiro et al. published their patent in 2010 |CAS: 38939-88-7

The Article related to aminobenzimidazole preparation gastric acid secretion inhibitor, proton potassium atpase inhibitor aminobenzimidazole preparation, peptic ulcer zollinger ellison syndrome prevention treatment aminobenzimidazole preparation, gastritis gastroesophageal reflux disease gerd prevention treatment aminobenzimidazole preparation and other aspects.Synthetic Route of 38939-88-7

On March 25, 2010, Kajino, Masahiro; Imaeda, Toshihiro; Ono, Koji; Aso, Kazuyoshi; Tarui, Naoki published a patent.Synthetic Route of 38939-88-7 The title of the patent was Preparation of 2-aminobenzimidazole derivatives as gastric acid secretion inhibitors. And the patent contained the following:

There are disclosed acid secretion inhibitors containing compounds represented by formula [I; R1’s may be the same or different and each represents a hydrogen atom, a halogen atom, an optionally substituted hydrocarbon group, an optionally substituted heterocyclic group, an optionally substituted alkoxy group, a hydroxy group or an optionally substituted amino group; R2 represents a hydrogen atom or a substituent; R3 represents a hydrogen atom or a substituent; ring A represents an optionally substituted carbon ring or an optionally substituted heterocyclic ring; and n represents an integer of 1-4], salts thereof, or prodrugs of the compounds or salts. These compounds inhibit proton,potassium-ATPase (H+/K+-ATPase) and are useful as gastric acid secretion inhibitors. There is also provided the preventive or therapeutic method for peptic ulcer, Zollinger-Ellison syndrome, gastritis, gastroesophageal reflux disease (GERD), symptomatic gastroesophageal reflux disease (symptomatic GERD), Barrett esophagus, functional dyspepsia, gastric cancer (stomach cancer), gastric MALT lymphoma, ulcer caused by nonsteroidal antiinflammatory agents, ulcer or hyper-gastric acidity (excessive acid secretion) caused by postsurgical stress, acute stress ulcer, hemorrhagic gastritis, stress, or upper digestive tract hemorrhage by administering the compound in mammals. Thus, a solution of 666 mg benzene-1,2-diamine in 30 mL THF was treated with 1.08 g 2-isothiocyanato-1,3,5-trimethyl benzene, refluxed for 4 h, treated with 2.24 g 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride, and refluxed for 50 min to give, after workup and recrystallization from EtOAc/hexane, 253 mg N-(2,4,6-trimethylphenyl)-1H-benzimidazol-2-amine (II). II N-(4-fluoro-2,6-dimethylphenyl)-5-methoxy-4-methyl-1H-benzimidazol-2-amine (III) showed IC50 of 970 and 14 nM, resp., against H+/K+-ATPase. A tablet formulation containing I was described. The experimental process involved the reaction of 2-Chloro-4-methyl-1-nitrobenzene(cas: 38939-88-7).Synthetic Route of 38939-88-7

The Article related to aminobenzimidazole preparation gastric acid secretion inhibitor, proton potassium atpase inhibitor aminobenzimidazole preparation, peptic ulcer zollinger ellison syndrome prevention treatment aminobenzimidazole preparation, gastritis gastroesophageal reflux disease gerd prevention treatment aminobenzimidazole preparation and other aspects.Synthetic Route of 38939-88-7

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics